Skip to main content

Table 4 NIS expression in extrathyroidal cancer tissues

From: Sodium iodide symporter (NIS) in extrathyroidal malignancies: focus on breast and urological cancer

Primary cancer

No of specimens

NIS mRNA

NIS protein positive (%)

References

Bladder

24

n.d.

42

[13]

Cervix

11

n.d.

100

[13]

Colon

75

n.d.

63

[13]

Esophagus

15

n.d.

47

[13]

 

20

n.d.

20

[13]

Liver

26

+

8

[74]

 

20*

+

100

[74]

Lung

58

n.d.

66

[13]

Ovary

37

n.d.

73

[13]

Pancreas

11

n.d.

64

[13]

Prostate

34

n.d.

74

[13]

Skin squamous

18

n.d.

56

[13]

Stomach

27

n.d.

59

[13]

 

4

+

n.d.

[12]

Submandibular gland

3

+

n.d.

[12]

Testis

11

n.d.

9

[13]

 

107

+

64

[75]

Uterus endometrium

25

n.d.

56

[13]

Metastatic cancer

    

Liver**

15

n.d.

80

[76]

Brain***

28

n.d.

84

[40]

  1. n.d.: not determined; *cholangiocarcinoma; **metastasis from breast, pancreas, colorectal and biliary cancers; ***metastasis from breast cancer.